Berenberg Bank Increases Synthomer (LON:SYNT) Price Target to GBX 170 - MarketBeat

2023-01-13 04:34:26 By : Ms. Ruby Pan

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

Synthomer (LON:SYNT - Get Rating) had its price objective lifted by equities researchers at Berenberg Bank from GBX 160 ($1.94) to GBX 170 ($2.07) in a report released on Wednesday, LSE.Co.UK reports. The firm currently has a "buy" rating on the stock. Berenberg Bank's price target indicates a potential upside of 25.00% from the company's previous close. Hypromellose E5

Berenberg Bank Increases Synthomer (LON:SYNT) Price Target to GBX 170 - MarketBeat

A number of other brokerages have also recently weighed in on SYNT. JPMorgan Chase & Co. dropped their price target on Synthomer from GBX 350 ($4.25) to GBX 260 ($3.16) and set a "neutral" rating for the company in a research report on Monday, October 3rd. Barclays reissued an "equal weight" rating and issued a GBX 323 ($3.92) price target on shares of Synthomer in a research note on Tuesday, November 8th. One research analyst has rated the stock with a sell rating, two have issued a hold rating and two have issued a buy rating to the company's stock. According to MarketBeat, Synthomer has a consensus rating of "Hold" and an average price target of GBX 345.60 ($4.20).Synthomer Price Performance

Synthomer stock opened at GBX 136 ($1.65) on Wednesday. The business has a 50 day simple moving average of GBX 124.87 and a 200-day simple moving average of GBX 176.11. The stock has a market capitalization of £635.58 million and a PE ratio of 680.00. The company has a debt-to-equity ratio of 114.88, a current ratio of 1.60 and a quick ratio of 0.97. Synthomer has a 12 month low of GBX 83 ($1.01) and a 12 month high of GBX 414.40 ($5.03). Insider Buying and Selling at Synthomer

In other news, insider Dato' Lee Hau Hian purchased 60,000 shares of the company's stock in a transaction that occurred on Monday, October 24th. The shares were acquired at an average cost of GBX 102 ($1.24) per share, with a total value of £61,200 ($74,344.02). In other Synthomer news, insider Roberto Gualdoni purchased 25,000 shares of the firm's stock in a transaction dated Wednesday, October 5th. The stock was bought at an average price of GBX 121 ($1.47) per share, with a total value of £30,250 ($36,746.84). Also, insider Dato' Lee Hau Hian acquired 60,000 shares of the business's stock in a transaction dated Monday, October 24th. The stock was purchased at an average price of GBX 102 ($1.24) per share, with a total value of £61,200 ($74,344.02). Synthomer Company Profile (Get Rating)

Synthomer plc operates as a specialty chemicals company. It operates through four segments: Performance Elastomers, Functional Solutions, Industrial Specialities, and Acrylate Monomers. The company offers pressure sensitive adhesives, acrylic polymers, acrylic dispersions, saturants, release coatings, and other adhesives; water-based carboxylated styrene butadiene rubber, redispersible powder, flooring adhesive, and additives for construction applications; and impregnation binders, styrene butadiene copolymers, dispersions, polymer binders, and butadiene-based binders for textiles applications.Further ReadingWill AMC's Troubles Affect Its Landlord, EPR Properties?Is There a Prize in Store for Kellogg Shareholders? General Mills Retreats To More Attractive Territory Will Tesla Shares Rally If Musk Steps Down From Twitter? 5 Down But Not Out Stocks To Watch For 2023

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to

Before you consider Synthomer, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Synthomer wasn't on the list.

While Synthomer currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Click the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise.

Thinking about investing in Meta, Roblox, or Unity? Enter your email below to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

326 E 8th St #105, Sioux Falls, SD 57103 (844) 978-6257

© American Consumer News, LLC dba MarketBeat® 2010-2023. All rights reserved.

Berenberg Bank Increases Synthomer (LON:SYNT) Price Target to GBX 170 - MarketBeat

Weiken Hpmc © 2023 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.